CIBA LAUNCHING FASTER ACTING DICLOFENAC-BASED PRESCRIPTION NSAID
This article was originally published in The Tan Sheet
Executive Summary
CIBA LAUNCHING FASTER ACTING DICLOFENAC-BASED PRESCRIPTION NSAID under the brandname Cataflam. Approved by FDA on Nov. 2,4, 1993, Cataflam (diclofenac potassium) is a slightly altered version of Ciba's Voltaren (diclofenac sodium), which has been marketed in the U.S. as a nonsteroidal anti-inflammatory agent since 1988. Cataflam was introduced to the trade in early February.